SGN-ALPV clinical trials

A Phase 1 Study of SGN-ALPV in Advanced Solid Tumors

This early-stage study is testing a new treatment called SGN-ALPV for advanced solid cancers, including certain stomach, lung, and gynaecological cancers. It's looking closely at how safe the treatment is and what side effects it might cause when first given to people.